PMID- 28054559 OWN - NLM STAT- MEDLINE DCOM- 20181102 LR - 20181113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 7 DP - 2017 Jan 5 TI - The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells. PG - 39727 LID - 10.1038/srep39727 [doi] LID - 39727 AB - A recent study demonstrated that advanced glycation end products (AGEs) play a role in monocyte infiltration in mesangial areas in diabetic nephropathy. The Ras homolog gene family, member A Rho kinase (RhoA/ROCK) pathway plays a role in regulating cell migration. We hypothesized that the RhoA/ROCK pathway affects adhesion and inflammation in endothelial cells induced by AGEs. Rat glomerular endothelial cells (rGECs) were cultured with AGEs (80 mug/ml) in vitro. The ROCK inhibitor Y27632 (10 nmol/l) and ROCK1-siRNA were used to inhibit ROCK. We investigated levels of the intercellular adhesion molecule 1 (ICAM-1) and monocyte chemoattractant protein1 (MCP-1) in rGECs. Db/db mice were used as a diabetes model and received Fasudil (10 mg/kg/d, n = 6) via intraperitoneal injection for 12 weeks. We found that AGEs increased the expression of ICAM-1 and MCP-1 in rGECs, and the RhoA/ROCK pathway inhibitor Y27632 depressed the release of adhesion molecules. Moreover, blocking the RhoA/ROCK pathway ameliorated macrophage transfer to the endothelium. Reduced expression of adhesion molecules and amelioration of inflammatory cell infiltration in the glomerulus were observed in db/db mice treated with Fasudil. The RhoA/ROCK pathway plays a role in adhesion molecule expression and inflammatory cell infiltration in glomerular endothelial cells induced by AGEs. FAU - Rao, Jialing AU - Rao J AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Ye, Zengchun AU - Ye Z AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Tang, Hua AU - Tang H AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Wang, Cheng AU - Wang C AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Peng, Hui AU - Peng H AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Lai, Weiyan AU - Lai W AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Li, Yin AU - Li Y AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Huang, Wanbing AU - Huang W AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. FAU - Lou, Tanqi AU - Lou T AD - Division of Nephrology, Department of Medicine, The Third Affiliated Hospital of Sun Yet-sen University, Guangzhou, Guangdong 510630, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20170105 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Amides) RN - 0 (Ccl2 protein, rat) RN - 0 (Chemokine CCL2) RN - 0 (Glycation End Products, Advanced) RN - 0 (Protein Kinase Inhibitors) RN - 0 (Pyridines) RN - 0 (RNA, Small Interfering) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - 138381-45-0 (Y 27632) RN - 84477-87-2 (1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine) RN - EC 2.7.11.1 (ROCK1 protein, rat) RN - EC 2.7.11.1 (rho-Associated Kinases) RN - EC 3.6.5.2 (rhoA GTP-Binding Protein) RN - Q0CH43PGXS (fasudil) SB - IM MH - 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives/therapeutic use MH - Amides/pharmacology MH - Animals MH - Cell Adhesion MH - Cell Movement MH - Cells, Cultured MH - Chemokine CCL2/metabolism MH - Diabetic Nephropathies/drug therapy/immunology/*metabolism MH - Disease Models, Animal MH - Endothelial Cells/*physiology MH - Glycation End Products, Advanced/metabolism MH - Inflammation/drug therapy/immunology/*metabolism MH - Intercellular Adhesion Molecule-1/metabolism MH - Kidney Glomerulus/*pathology MH - Mice MH - Mice, Mutant Strains MH - Protein Kinase Inhibitors/therapeutic use MH - Pyridines/pharmacology MH - RNA, Small Interfering/genetics MH - Rats MH - Signal Transduction MH - rho-Associated Kinases/antagonists & inhibitors/genetics/*metabolism MH - rhoA GTP-Binding Protein/*metabolism PMC - PMC5215591 EDAT- 2017/01/06 06:00 MHDA- 2018/11/06 06:00 PMCR- 2017/01/05 CRDT- 2017/01/06 06:00 PHST- 2015/10/29 00:00 [received] PHST- 2016/11/28 00:00 [accepted] PHST- 2017/01/06 06:00 [entrez] PHST- 2017/01/06 06:00 [pubmed] PHST- 2018/11/06 06:00 [medline] PHST- 2017/01/05 00:00 [pmc-release] AID - srep39727 [pii] AID - 10.1038/srep39727 [doi] PST - epublish SO - Sci Rep. 2017 Jan 5;7:39727. doi: 10.1038/srep39727.